+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Theragnostics, An Issue of PET Clinics. The Clinics: Radiology Volume 19-3

  • Book

  • June 2024
  • Elsevier Health Science
  • ID: 5940137
- Contains 12 relevant, practice-oriented topics including theragnostics trials; neuroendocrine tumors: diagnostics; prostate-specific membrane antigen: diagnostics; theragnostics: post-therapy imaging; fibroblast-activation-protein inhibitors (FAPI) theragnostics; and more.- Provides in-depth clinical reviews on theragnostics, offering actionable insights for clinical practice.- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.In this issue of PET Clinics, guest editors Drs. Andrei Iagaru and Heather A. Jacene bring their considerable expertise to the topic of Theragnostics. Top experts in the field discuss neuroendocrine tumors: beta-labeled peptides; prostate-specific membrane antigen: interpretation criteria, standardized reporting and the use of artificial intelligence; prostate cancer (gastrin-releasing peptide receptor); selective internal radiation therapy; future directions in theragnostics; and more.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

Alpha and Beta Radiation for Theragnostics
Neuroendocrine Tumors: Diagnostics
Alpha-emitter Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors
Prostate-specific Membrane Antigen: Diagnostics
Prostate-specific Membrane Antigen: Interpretation Criteria, Standardized Reporting, and the Use of Machine Learning
Prostate-specific Membrane Antigen: Alpha-labeled Radiopharmaceuticals
Prostate Cancer Radioligand Therapy: Beta-labeled Radiopharmaceuticals
Gastrin Releasing Peptide Receptors-targeted PET Diagnostics and Radionuclide Therapy for Prostate Cancer Management: Preclinical and Clinical Developments of the Past 5 Years
Treatment Response Imaging in Prostate Cancer
Hepatic Radioembolization: A Multistep Theragnostic Procedure

Authors

Andrei Iagaru Nuclear Medicine, Stanford, CA, USA. Heather A. Jacene Department of Radiology
Brigham and Women's Hospital
Harvard Medical School.